Bio-Rad Laboratories Inc (NYSE:BIO)
$ 330.53 2.17 (0.66%) Market Cap: 9.23 Bil Enterprise Value: 9.00 Bil PE Ratio: 0 PB Ratio: 1.24 GF Score: 78/100

Q4 2021 Bio Rad Laboratories Inc Earnings Call Transcript

Feb 10, 2022 / 11:00PM GMT
Release Date Price: $625.17 (-1.89%)
Operator

Good evening. Thank you for attending today's Bio-Rad Laboratories Q4 and Full Year Financial Results Conference Call. My name is Hannah, and I will be your moderator for today's call. (Operator Instructions) I would now like to pass the conference over to our host, Edward Chung, Head of Investor Relations with Bio-Rad. Please go ahead.

Yong Chung
Bio-Rad Laboratories, Inc. - VP of IR

Thanks, Anna. Good afternoon, and thank you all for joining us. Today, we will review the fourth quarter and full year 2021 financial results and provide an update on key business trends for Bio-Rad.

With me on the phone today are Norman Schwartz, our Chief Executive Officer; Ilan Daskal, Executive Vice President and Chief Financial Officer; Andy Last, Executive Vice President and Chief Operating Officer; Simon May, President of the Life Science Group; and Dara Wright, President of the Clinical Diagnostics Group.

Before we begin our review, I would like to caution everyone that we will be making forward-looking statements about management's goals, plans and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot